Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

CHARLES E ARGOFF

Allopathic & Osteopathic Physicians Psychiatry & Neurology Neurology

NPI
1073673125
CMS profile
93628
Location
ALBANY, NY

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2022 · Entire year

$189,323.58

213 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2022 · entire year · sorted by reported total

By paying entity

PY2022 · entire year · sorted by reported total

Paying entityAmountRecords
ABBVIE INC. $34,913.56 61
Collegium Pharmaceutical, Inc. $31,122.03 17
Lilly USA, LLC $22,974.79 29
GRT US Holding, Inc. $16,440.73 28
Biohaven Pharmaceutical Holding Company Ltd. $16,197.06 24
IMPEL PHARMACEUTICALS INC. $11,892.89 9
GlaxoSmithKline, LLC. $11,002.22 1
Lundbeck LLC $10,860.75 7
Nevro Corp. $8,096.24 9
Teva Pharmaceuticals USA, Inc. $7,525.11 9
Kowa Pharmaceuticals America, Inc. $7,133.13 7
Ironwood Pharmaceuticals, Inc $4,752.94 2
Amgen Inc. $2,805.00 2
Tris Pharma Inc $2,642.00 2
Allergan, Inc. $750.00 1
Nalu Medical, Inc. $125.87 1
UROVANT SCIENCES INC $41.99 2
SK Life Science, Inc. $24.06 1
Medtronic, Inc. $23.21 1

Page 2 of 5; records 51–100 of 213 matching records. This page contains 50 records (maximum 50), not the full filtered export. Use the CSV download for all matching records.

IndustryPayments · General Payments

CHARLES E ARGOFF

NPI 1073673125 · CMS profile ID 93628

Allopathic & Osteopathic Physicians / Psychiatry & Neurology / Neurology

ALBANY, NY

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

General Payments, PY2022; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types

Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00

Page 2 of 5; records 51–100 of 213 matching records. This page contains 50 records (maximum 50), not the full filtered export.

Filtered page: https://industrypayments.org/provider/npi-1073673125?year=2022&recipient=provider&page=2#records-h

CMS source: https://openpaymentsdata.cms.gov/dataset/df01c2f8-dc1f-4e79-96cb-8208beaf143c

Cite these filtered records

The citation includes this program year, filters, data edition, and page of results.

Plain
CHARLES E ARGOFF, NPI 1073673125, CMS profile ID 93628. General Payments, PY2022; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 2 of 5; records 51–100 of 213 matching records. This page contains 50 records (maximum 50), not the full filtered export. IndustryPayments. https://industrypayments.org/provider/npi-1073673125?year=2022&recipient=provider&page=2#records-h. Source: https://openpaymentsdata.cms.gov/dataset/df01c2f8-dc1f-4e79-96cb-8208beaf143c.
APA 7
IndustryPayments. (2026). CHARLES E ARGOFF, NPI 1073673125, CMS profile ID 93628. General Payments, PY2022; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 2 of 5; records 51–100 of 213 matching records. This page contains 50 records (maximum 50), not the full filtered export. [Filtered data set page]. https://industrypayments.org/provider/npi-1073673125?year=2022&recipient=provider&page=2#records-h. Source: https://openpaymentsdata.cms.gov/dataset/df01c2f8-dc1f-4e79-96cb-8208beaf143c.
Bluebook
CHARLES E ARGOFF, NPI 1073673125, CMS profile ID 93628, IndustryPayments, General Payments, PY2022; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types (Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00). Page 2 of 5; records 51–100 of 213 matching records. This page contains 50 records (maximum 50), not the full filtered export. Source: https://openpaymentsdata.cms.gov/dataset/df01c2f8-dc1f-4e79-96cb-8208beaf143c. https://industrypayments.org/provider/npi-1073673125?year=2022&recipient=provider&page=2#records-h.

Centers for Medicare & Medicaid Services, Open Payments

Citation formats are provided for reference; check the requirements of your publication.

Payment records · PY2022

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2022 · Physicians and non-physician practitioners · CMS publication 2026-06-30

213 matching records · $189,323.58 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 213 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 51–100 of 213.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
Lilly USA, LLC $22.0010/06/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 917940243 CMS
Lilly USA, LLC $51.7510/06/2022 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 917943031 CMS
ABBVIE INC. $4.8310/05/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 890521091 CMS
Biohaven Pharmaceutical Holding Company Ltd. $2.8610/05/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 923528351 CMS
IMPEL PHARMACEUTICALS INC. $1,704.0010/04/2022 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 962309297 CMS
Lilly USA, LLC $2,500.0010/04/2022 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 917940377 CMS
Lilly USA, LLC $1,575.0010/04/2022 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 917940379 CMS
GRT US Holding, Inc. $151.2010/01/2022 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 894603869 CMS
Teva Pharmaceuticals USA, Inc. $23.9509/28/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 954419755 CMS
ABBVIE INC. $11.0009/27/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 890521089 CMS
IMPEL PHARMACEUTICALS INC. $5.9609/27/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 962309283 CMS
IMPEL PHARMACEUTICALS INC. $47.0009/27/2022 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 962309285 CMS
IMPEL PHARMACEUTICALS INC. $852.0009/27/2022 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 962309295 CMS
Lundbeck LLC $2.2909/27/2022 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 945724157 CMS
Lundbeck LLC $4,655.0009/27/2022 Honoraria No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 945724161 CMS
Lundbeck LLC $41.1309/27/2022 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 945724165 CMS
Biohaven Pharmaceutical Holding Company Ltd. $5.6009/21/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 923528347 CMS
Biohaven Pharmaceutical Holding Company Ltd. $5.1509/21/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 923528349 CMS
IMPEL PHARMACEUTICALS INC. $103.3809/21/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 962309291 CMS
IMPEL PHARMACEUTICALS INC. $4,000.0009/16/2022 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 962309279 CMS
Biohaven Pharmaceutical Holding Company Ltd. $13.1909/14/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 923528343 CMS
Biohaven Pharmaceutical Holding Company Ltd. $1.9909/14/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 923528345 CMS
Collegium Pharmaceutical, Inc. $54.4109/09/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 914512329 CMS
Collegium Pharmaceutical, Inc. $2,800.0009/08/2022 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 914587297 CMS
Collegium Pharmaceutical, Inc. $3,000.0009/08/2022 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 914587301 CMS
Tris Pharma Inc $2,500.0009/08/2022 Honoraria No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 962112735 CMS
Tris Pharma Inc $142.0009/08/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 962112741 CMS
Kowa Pharmaceuticals America, Inc. $32.9909/07/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 900412049 CMS
Kowa Pharmaceuticals America, Inc. $47.6509/07/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 900412053 CMS
ABBVIE INC. $4.2309/01/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 890521087 CMS
ABBVIE INC. $1,500.0008/31/2022 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 890521085 CMS
ABBVIE INC. $8.9208/26/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 890521083 CMS
Lilly USA, LLC $5.3908/17/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 917943037 CMS
ABBVIE INC. $13.5508/10/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 890521081 CMS
ABBVIE INC. $1,800.0008/05/2022 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 890521079 CMS
Lilly USA, LLC $112.2508/05/2022 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 917936595 CMS
Lilly USA, LLC $4.6808/05/2022 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 917938825 CMS
Lilly USA, LLC $18.5008/05/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 917940851 CMS
IMPEL PHARMACEUTICALS INC. $1,136.0008/03/2022 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 962309289 CMS
Biohaven Pharmaceutical Holding Company Ltd. $774.2007/29/2022 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 923528341 CMS
ABBVIE INC. $6.0007/28/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 890521077 CMS
Biohaven Pharmaceutical Holding Company Ltd. $3,500.0007/28/2022 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 923528337 CMS
Biohaven Pharmaceutical Holding Company Ltd. $58.3807/28/2022 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 923528339 CMS
ABBVIE INC. $1,800.0007/27/2022 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 890521075 CMS
ABBVIE INC. $23.1107/26/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 890521073 CMS
Biohaven Pharmaceutical Holding Company Ltd. $3,000.0007/25/2022 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 923528331 CMS
Biohaven Pharmaceutical Holding Company Ltd. $7.5007/25/2022 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 923528333 CMS
Biohaven Pharmaceutical Holding Company Ltd. $133.4007/25/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 923528335 CMS
Lilly USA, LLC $1,575.0007/21/2022 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 917940383 CMS
Lilly USA, LLC $2,500.0007/21/2022 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 917942457 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $225,786.41 275
PY2020 $180,509.15 157
PY2021 $203,081.18 165
PY2022 $189,323.58 213
PY2023 $163,278.68 134
PY2024 $84,852.87 138
PY2025 $161,021.84 212

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2021, 2022, 2023, 2024, 2025
Source files and profile matching
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Research Payments

One row per program year and role, newest year first · amounts for the two roles are never added together

Program yearRoleAmountRecords
PY2025 Principal investigator $58,333.06 20
PY2024 Principal investigator $199,087.01 48
PY2023 Principal investigator $107,973.52 44
PY2022 Recipient $6,173.63 10
PY2022 Principal investigator $28,422.93 60
PY2021 Recipient $490.00 1
PY2021 Principal investigator $63,874.13 69
PY2020 Principal investigator $59,075.01 23
PY2019 Recipient $947.00 1
PY2019 Principal investigator $15,138.15 1

Research Payments are a separate CMS dataset, shown here separately and never added to General Payments. A research payment is often made to an institution, with this provider named as a principal investigator; each record states which role applies.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

Research Payments records · PY2025

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

20 records in PY2025

Research Payments records (CSV)

RolePaying entityAmount DateRecipientStudy Dispute statusPublishedRecord ID
Principal investigator 1 ABBVIE INC. $1,854.00 12/31/2025 Non-covered Recipient Entity
ALBANY MEDICAL COLLEGE
A Phase 3 Multicenter 24-Week Open-Label Study to Evaluate the Safety, Tolerability, and Efficacy of Atogepant When Added to OnabotulinumtoxinA (BOTOX) for the Preventive Treatment of Chronic Migraine No dispute reported 06/30/2026 1202535123
Principal investigator 1 H. Lundbeck A S $1,449.00 10/15/2025 Covered Recipient Teaching Hospital
ALBANY MEDICAL CENTER HOSPITAL
A Trial of Eptinezumab in Participants With Migraine and Insufficient Response to Anti-CGRP Medications No dispute reported 06/30/2026 1251765104
Principal investigator 1 Purdue Pharma L.P. $518.00 09/18/2025 Non-covered Recipient Entity
Albany Medical College
PMR 3033-11: Study 11 No dispute reported 06/30/2026 1239011333
Principal investigator 1 Purdue Pharma L.P. $1,332.00 09/18/2025 Non-covered Recipient Entity
Albany Medical College
PMR 3033-11: Study 11 No dispute reported 06/30/2026 1239011337
Principal investigator 1 H. Lundbeck A S $11,000.00 07/18/2025 Covered Recipient Teaching Hospital
ALBANY MEDICAL CENTER HOSPITAL
A Trial of Eptinezumab in Participants With Migraine and Insufficient Response to Anti-CGRP Medications No dispute reported 06/30/2026 1251765095
Principal investigator 1 H. Lundbeck A S $2,700.00 07/18/2025 Covered Recipient Teaching Hospital
ALBANY MEDICAL CENTER HOSPITAL
A Trial of Eptinezumab in Participants With Migraine and Insufficient Response to Anti-CGRP Medications No dispute reported 06/30/2026 1251765099
Principal investigator 1 ABBVIE INC. $1,350.00 07/10/2025 Non-covered Recipient Entity
ALBANY MEDICAL COLLEGE
Study of Oral Atogepant When Added to OnabotulinumtoxinA (BOTOX) to Assess Adverse Events and Change in Disease Activity in Adult Participants With Chronic Migraine No dispute reported 06/30/2026 1202498000
Principal investigator 1 Purdue Pharma L.P. $1,056.00 06/19/2025 Non-covered Recipient Entity
Albany Medical College
PMR 3033-11: Study 11 No dispute reported 06/30/2026 1239011327
Principal investigator 1 Purdue Pharma L.P. $4,411.09 06/19/2025 Non-covered Recipient Entity
Albany Medical College
PMR 3033-11: Study 11 No dispute reported 06/30/2026 1239011329
Principal investigator 1 Purdue Pharma L.P. $554.40 06/19/2025 Non-covered Recipient Entity
Albany Medical College
PMR 3033-11: Study 11 No dispute reported 06/30/2026 1239011331
Principal investigator 1 Purdue Pharma L.P. $924.00 06/05/2025 Non-covered Recipient Entity
Albany Medical College
PMR 3033-11: Study 11 No dispute reported 06/30/2026 1239011335
Principal investigator 1 VERTEX PHARMACEUTICALS INCORPORATED $2,268.00 03/25/2025 Non-covered Recipient Entity
ALBANY MEDICAL COLLEGE
A Phase 2, Randomized, Double-blind, Placebo-controlled, Parallel-design Study of the Efficacy and Safety of VX-548 in Subjects With Painful Lumbosacral Radiculopathy No dispute reported 06/30/2026 1214124170
Principal investigator 1 Purdue Pharma L.P. $1,221.00 03/20/2025 Non-covered Recipient Entity
Albany Medical College
PMR 3033-11: Study 11 No dispute reported 06/30/2026 1239011323
Principal investigator 1 Purdue Pharma L.P. $3,485.24 03/20/2025 Non-covered Recipient Entity
Albany Medical College
PMR 3033-11: Study 11 No dispute reported 06/30/2026 1239011325
Principal investigator 1 ABBVIE INC. $67.50 02/27/2025 Non-covered Recipient Entity
ALBANY MEDICAL COLLEGE
M22-418 - Study of Oral Atogepant When Added to OnabotulinumtoxinA (BOTOX) to Assess Adverse Events and Change in Disease Activity in Adult Participants With Chronic Migraine No dispute reported 06/30/2026 1202454557
Principal investigator 1 Purdue Pharma L.P. $858.00 02/06/2025 Non-covered Recipient Entity
Albany Medical College
PMR 3033-11: Study 11 No dispute reported 06/30/2026 1239011317
Principal investigator 1 Purdue Pharma L.P. $1,122.00 02/06/2025 Non-covered Recipient Entity
Albany Medical College
PMR 3033-11: Study 11 No dispute reported 06/30/2026 1239011319
Principal investigator 1 Purdue Pharma L.P. $3,123.12 02/06/2025 Non-covered Recipient Entity
Albany Medical College
PMR 3033-11: Study 11 No dispute reported 06/30/2026 1239011321
Principal investigator 1 ABBVIE INC. $2,700.00 01/02/2025 Non-covered Recipient Entity
ALBANY MEDICAL COLLEGE
M22-418 - Study of Oral Atogepant When Added to OnabotulinumtoxinA (BOTOX) to Assess Adverse Events and Change in Disease Activity in Adult Participants With Chronic Migraine No dispute reported 06/30/2026 1202435505
Principal investigator 1 VERTEX PHARMACEUTICALS INCORPORATED $16,339.71 01/01/2025 Non-covered Recipient Entity
ALBANY MEDICAL COLLEGE
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-design Study of the Efficacy and Safety of Suzetrigine in Subjects With Painful Diabetic Peripheral Neuropathy No dispute reported 06/30/2026 1214124440